21 Results for "

Leflunomide

" in MedChemExpress (MCE) Product Catalog:
Products (21)

21 Results for "Leflunomide" in MCE Product Catalog:

21
21 Publications Verification
Cat. No.: HY-B0083
CAS No.: 75706-12-6
Synonyms: HWA486; RS-34821; SU101
Research Areas:  

Cancer

Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-15405
CAS No.: 163451-81-8
Purity:  99.92%
Synonyms: A77 1726
Teriflunomide is the active metabolite of leflunomide, an approved therapy for rheumatoid arthritis. It inhibits pyrimidine synthesis and therefore potently decreases T cell and B cell proliferation.
loading...
    loading...
Cat. No.: HY-101813
CAS No.: 147076-36-6
Purity:  99.76%
Synonyms: HR325
Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). Laflunimus suppresses immunoglobulin (Ig) secretion, with IC50 values of 2.5 and 2 µM for IgM and IgG, respectively. Laflunimus also is a prostaglandin endoperoxide H synthase (PGHS) -1 and -2 inhibitor .
loading...
    loading...
Cat. No.: HY-135648
CAS No.: 183945-55-3
Purity:  99.12%
Research Areas:  

Infection

PfDHODH-IN-1 is an analogue of the active metabolite of Leflunomide. PfDHODH-IN-1 is a Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitor. PfDHODH-IN-1 has antimalarial activity .
loading...
    loading...
Cat. No.: HY-B0083S
CAS No.: 1189987-23-2
Leflunomide-d4 (HWA486-d4) is the deuterium labeled Leflunomide. Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent .
loading...
    loading...
Cat. No.: HY-77324R
CAS No.: 455-14-1
Synonyms: 4-Aminobenzotrifluoride (Standard)
Research Areas:  

Others

4-(Trifluoromethyl)aniline (Standard) is the analytical standard of 4-(Trifluoromethyl)aniline. This product is intended for research and analytical applications. 4-(Trifluoromethyl) aniline (4-Aminobenzotrifluoride) is an aromatic amine and also a synthetic building block for fluorinated α-aminophosphonates. 4-(Trifluoromethyl) aniline is an impurity of Leflunomide .
loading...
    loading...
Cat. No.: HY-77324S
CAS No.: 1219795-48-8
Synonyms: 4-Aminobenzotrifluoride-d4
4-(Trifluoromethyl)aniline-d4 (4-Aminobenzotrifluoride-d4) is deuterium labeled 4-(Trifluoromethyl)aniline.4-(Trifluoromethyl) aniline (4-Aminobenzotrifluoride) is an aromatic amine and also a synthetic building block for fluorinated α-aminophosphonates. 4-(Trifluoromethyl) aniline is an impurity of Leflunomide .
loading...
    loading...
Cat. No.: HY-135675
CAS No.: 1263303-95-2
Purity:  99.69%
DHODH-IN-11 (Compound 14b) is a Leflunomide derivative and a weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03 .
loading...
    loading...
Cat. No.: HY-77324
CAS No.: 455-14-1
Synonyms: 4-Aminobenzotrifluoride
Target:  

Drug Intermediate

Research Areas:  

Others

4-(Trifluoromethyl) aniline (4-Aminobenzotrifluoride) is an aromatic amine and also a synthetic building block for fluorinated α-aminophosphonates. 4-(Trifluoromethyl) aniline is an impurity of Leflunomide .
loading...
    loading...
Cat. No.: HY-B0083R
CAS No.: 75706-12-6
Synonyms: HWA486 (Standard); RS-34821 (Standard); SU101 (Standard)
Leflunomide (Standard) is the analytical standard of Leflunomide. This product is intended for research and analytical applications. Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent.
loading...
    loading...
Cat. No.: HY-B0083S1
Synonyms: HWA486-13C6; RS-34821-13C6; SU101-13C6
Leflunomide- 13C6 (HWA486- 13C6) is 13C labeled Leflunomide. Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent.
loading...
    loading...
Cat. No.: HY-135676
CAS No.: 1263303-93-0
DHODH-IN-12 (Compound 12b) is a Leflunomide derivative and a weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.07 .
loading...
    loading...
Cat. No.: HY-Z8375
CAS No.: 1403564-06-6
Synonyms: Leflunomide impurity F
Target:  

Drug Intermediate

Research Areas:  

Others

Leflunomide impurity 1 (Leflunomide impurity F) is an impurity of Leflunomide.
loading...
    loading...
Cat. No.: HY-W011669
CAS No.: 61643-23-0
Synonyms: Leflunomide 3-Isomer
Target:  

Drug Intermediate

Research Areas:  

Others

Leflunomide impurity 3 (Leflunomide 3-Isomer) is an impurity of Leflunomide.
loading...
    loading...
Cat. No.: HY-135654
CAS No.: 183946-00-1
hDHODH-IN-2 is an analogue of the active metabolite of Leflunomide. hDHODH-IN-2 is a human dihydroorotate dehydrogenase (hDHODH) inhibitor. hDHODH-IN-1 has anti-inflammatory activity .
loading...
    loading...
Cat. No.: HY-15405R
CAS No.: 163451-81-8
Synonyms: A77 1726 (Standard)
Teriflunomide (Standard) is the analytical standard of Teriflunomide. This product is intended for research and analytical applications. Teriflunomide is the active metabolite of leflunomide, an approved therapy for rheumatoid arthritis. It inhibits pyrimidine synthesis and therefore potently decreases T cell and B cell proliferation.
loading...
    loading...
Cat. No.: HY-78861
CAS No.: 24522-30-3
Target:  

Drug Intermediate

Research Areas:  

Others

Leflunomide impurity 7 is an impurity of Leflunomide.
loading...
    loading...
Cat. No.: HY-W010434
CAS No.: 42831-50-5
Target:  

Drug Intermediate

Research Areas:  

Others

Leflunomide impurity 4 is an impurity of Leflunomide.
loading...
    loading...
Cat. No.: HY-Z8374
CAS No.: 208401-20-1
Target:  

Drug Intermediate

Research Areas:  

Others

Leflunomide impurity 5 is an impurity of Leflunomide.
loading...
    loading...
Cat. No.: HY-101813R
CAS No.: 147076-36-6
Synonyms: HR325 (Standard)
Laflunimus (Standard) is the analytical standard of Laflunimus. This product is intended for research and analytical applications. Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). Laflunimus suppresses immunoglobulin (Ig) secretion, with IC50 values of 2.5 and 2 μM for IgM and IgG, respectively. Laflunimus also is a prostaglandin endoperoxide H synthase (PGHS) -1 and -2 inhibitor .
loading...
    loading...